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'lbe mouse skin tumor model was used to investigate whether 
the Ievel of DNA 8dducts and/or the rate of cell division in 
the epidermis are indicators of the risk of cancer formation 
for an individual in an outbred animal popul8tion. A high 
risk was considered to be reftected by 8 short latency period 
for the 8ppearance of 8 papilloma. Fernale NMRI mice were 
treated twice weekly with 2.5 nmol 7 ,12-dimethylbenz[a]an-
tbracene (DMBA) and 3 nmoi12-0-tetradecanoylphorbol-13-
8cetate (TPA) and the appearance of papillomas was 
registered. The first papilloma 8ppeared after 7.5 weeks. 
After 17 weeks, when 12 of 14 mice bad 8t least one 
papilloma, an osmotic minipump deliverlog 5-bromo-2'-
deoxyuridine (BrdU) was implanted into eacb mouse for 24 
h. The mice were killed after 24 h ~d the epidermis was 
analyzed for D:MBA-nucleotide 8dducts by 32p.postlabeling, 
for the cell number per unit skin length, and for the labeling 
index for DNA synthesls. Unexpectedly, D:MBA-nucleotide 
8dduct Ievels were highest in those anima1s wbich showed the 
Iongest latency periods. Adduct Ievels were negatively 
correlated with the 18beling index, indicating that dilution of 
adducts by cell division was a predominant factor in 
determining average adduct concentrations. Individual 
tumor-latency time was not corTelated with either cell ntunber 
or labeling index. This could be due to the fact that the 
measurements only provided 8veraged data and gave no 
infonnation on the specific situation in clones of premalignant 
cells. Under the conditions of tbis assay, therefore, neither 
DNA adduct Ievels nor information on the average kinetics 
of cell division bad a predidive value for the individual amcer 
risk withln a group of outbred animals receiving the same 
treatment. 
Introducdon 
The risk of an individual to develop a carcinogen-induced tumor 
is dependent upon heritable and Iife-style factors that detennine 
carcinogen metabolism leading to DNA adducts and rates ofDNA 
repair and cell division (1). The question is whether one or the 
other of these factors could be used as a predictive marker for 
an individual cancer risk. 
With the introduction of the 32P-postlabeling method, the 
measurement of DNA adducts in human samples has become a 
routine technique for biomonitaring exposure to carcinogens (2). 
Attempts to correlate adduct Ievels with cancer risk, however, 
have been hampered by the facts that (i) target tissue is not easily 
*Abbreviations: DMBA, 7,12-dimetbylbenz[a]antbracene; TPA, 12-0-
tetradccanoylphorbol-13-acerat.e; BrdU, 5-bromo-2' -deoxyuridine. 
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available and that (ü) 'individual cancer risk' is not weil defined. 
One study dealt with lung cancer patients undergoing surgery: 
it was found that the patients who were <55 years old had a 
higher Ievel of DNA adducts in bronchial biopsies as compared 
with the >55 year-old group (3). This finding could be 
interpreted as if high adduct Ievels could be responsible for a 
short latency period. Unfortunately, smoking habits in the weeks 
before surgery were not reported for the two groups. 
In this study, we investigated under experimental conditions 
whether DNA adduct Ievels andlor rates of cell division in the 
target tissue have a predictive value for the individual cancer risk. 
The mouse skin tumor model of Heckerand coworkers (4) was 
used. It allows a visual observation of the appearance of 
papillomas. The individual tumor latency time can be used as 
an indicator of the individual cancer risk. The mice were treated 
repeatedly with 7,12-dimethylbenz[a]anthracene (D:MBA*) as a 
DNA adduct-forming carcinogen and 12-0-tetradecanoylphorbol-
13-acetate (TPA) as a tumor-promoting agent affecting cell 
division and differentiation. This combined treatment was 
considered to best retlect chronic exposure of humans to both 
genotoxic and nongenotoxic carcinogens. The hypothesis was 
tested whether DNA adduct Ievels and/or rates of cell division 
are highest in those · animals where a skin papilloma is seen 
earliest. 
Materials and methods 
Chemieals 
The following sources were used: DMBA, acetone and proteinase K: Fluka AG, 
Buchs SG, Switzerland. TPA: LC Services Corporation (Wobum, MA, USA). 
['y-32P]ATP (7000 Cilmmol): ICN. RNase A (R-5125), RNase T1 (R-1003), 
nuclease P1 (N-8630), splecn phosphodiesterase (P-6752), microc:occal nuclease (N-3755), 5-bromo-2'-deoxyuridine (BrdU): Sigma. T4 polynucleotide kinase 
(70031): United States Biochemicals. Polyethyleneimine c:ellulose TLC plates: 
Macherey and Nagel. Anti-BrdU murine IgG: Becton Dickinson Co. (Research 
Triangle Park, NC). Super&CIISitive kit: Biogenex Laboratories lnc. (San Ramon, 
CA). 
Anima& and tre~nu 
Sixteen 6 week-old female NMRI mice (from Charles River Savo, Kisslegg, 
Germany) were housed, in groups of four, at 21 :t: 1 oc with a 12 b Iight/dark 
cycle (1 a.m.n p.m.) in IDICIOione cages type IV. Food (Nafag 890 from Nafag 
AG, Gossau, Switzedand) and water were given ad libinun. After 1 week, the 
backs were shaved (a swath 4 c:m long, 3 cm wide; Wella Minicut). Nine days 
later, the treatment with 2.5 nmol DMBA and 3 mno1 TPA in 100 ,d acetone 
Sillted (wedt 0) and was repeated twice weeldy (on Tuesday and Friday, SOlDdimes 
on Monday and Thursday). The lime of the fim appearance of a papüloma witb 
diameter > 1 mm was registeled for eatb animal. Two mice died spontaneously 
at weeks 10 and 12. Wben 12 of 14 mice showed at Jeasa one papiDoma, an osmotic 
minipump was implanted s.c. in all animals (Aizet 2001 D, ßow rare Bl'l/b for 
24 h; Alm Corp., Palo Alto, CA; 6JJed with 220 ,d of a so1ution of20 mg BrdU/ml 
10 mM porassium phosphate, 130 mM NaQ, pH 7.6 (PBS), plus 111 1 N NaOH). 
24 h 1ater, all mk:e were killed by an overdose of balodume. The treat.ed sldn 
ua and a piece of the sma'n inresdne were excised. A tumor-free part of the 
skin and the small intestine were prepared for the immunobistochemisUy, the 
remaining skin excluding papilloma was used to isolate DNA. 
DNA isolalion and »p-ponfabeling 
Tbe epidennis (without tumor-bearing areas) was saaped off witb a sc:alpel after 
brief warming of the skin to ssoc in a waterbath (S) and was stored a1 -80°C. 
DNA was isolated acconling to publisbed methods (6). Tbc DNA was dissolved 
in 'nucleotide buffer' (20 mM sodium succiDate, 8 mM CaCJ2, pH 6.0) and 
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stored at -so•c. DNA :eoilcentrations were estimated specuopbotomeaically 
~. an .Aucr~of20 'for a &Qiutiou of 1 mg/ml. 
3lp,;~l·Y~Qf'Q~!\~~~ ~~."'~ (7~~. 
~ght P,8 DNA:WäS digestect:ät38~C for ~.s h 'in 10 ~ 20 mM sodiWD suCci~We'-
8 mM. eaq,. pH· t;.n:~ ~co~, 2it iil' pJwspbodiest.emsc (0.048 ~ts> anc1 
1.321'8 1Pi~-~~~·(0.:24.:units). 8~5 pJ. of~·~B~-was-usedJ~nhe 
enriC.~ öf9iC iiddu~: t>y Sddi~ori ·of9.21 PJ. n~l~ Pi (l;7 wUts), 1.2 pl 
O.SS'iilM Zri02·ro eacll.~sampte-:and irteubation •at 3soc 'for-40 min. 4,4 jdof 
tbis hycm>l~,w~ iD~bared wi*"a.l pJ. nucleotidc. buft'er·:81Jd4.;-~ pJ. h9l.-niix. 
Q~ lic,I [~ . .;~~] Ap»,.Jß t4, ~~f(~r· (~Q9 J!IM. 'I)iS-I:fQ, P"ß.S, 
100 fuM'·~iimi clilöriÖe;, IOO~iDM :Ciiüiiodiieitöl, -10 mM:speniiidirie), 0.7 jd 
to-5'M.ArP; 3'units~pol)'llUCleoti® Jdha$e up to4.S pl widi:H20)·for4()_ min 
at I'OQm·•~~ .. Nf ~~es were ,lalJ,eled .in. o~ e•timel)*• 
~gl;d[ihy of 12P~Iolitkd nuc~liiks tmd qwmtjflcmwn 
~r·.rq use. ~EI.:~IMo~·p• ~\~~- with ~~and ~~r;:~• 
and ä ·Wbäülilh filier piipei (no •. 17) ·WiCit: wasi.8itactieö •. Nme ·pLof·:tbe: labelett 
mixhüe· were:appliecl-ön ä PEJ. pliue' äs'(lescribed. @) .. Pl&tes wae developed in· 
o:1 d~on·Qy_~pl wiib L7'M' 59dil1Pl ·phosp~,,,pH 6,oi ·ne Wi~~, ~ 
rem9v~.@d rm, .Sb~ ~"~ppec~ ·.in p~ di@ti9n ~i118·:4.3 M"litlüwn 'fo~ 
and 7~4 M Ure&, pß 3A. to:~ tbe:·separatibn:ot"tnc" spots, .ääoiher wick 
(LS cm; no.- l)was attached irl D4 d~on wtrich Y~&S·.developo(J.-witb~O·.J~ M 
sodium phqsp~. o~~s M Tris; J;(j,.M ~. pH: ,.2! Backgrol~Jl(l _radiQietjvity 
was tedileecfby ClevcloplQg-th'e_Sheet iD ·os cllrection.(same as Dl) u51Dg t.'fM: 
sodium pliosphate,. pH 6 .. 0, onro 'another wick (4 cm; no. 1). After e&:h 
developolent the plaies -~ \yas~ with water·for lP ~ :<t~mk'Wnh peqnanent 
water excbange). Imfn.ediatd)"~fc:Uoe•c:hrorJUUoäiaphy ·iß D3_~ 04, the biim 
were ptedeveloped -With watet ·ro - i an .trom the 'bottom ed.ae·. .For 
autol'lll;tiograpl)y, ~ XAR 0-t,dAT film ~:~:at·-~°C. ~'spots 
were cfut. OUt 8rid ~ir radic;NICtivity deteimined by Cerenkov c:owrtii'ig Üllbe 
scintillation counter (counting efticiency 33%). 
A~-le~els w~ cal~:~ tl)e nel radioa,ctivity·in tbc ~ve spot, 
takingd.ntb accoUnt·the ~· act~. oNhe [~3:zP)ATP at thC time of-~ 
and the: anlOUnt of DNA'hydrolysatt (2;24 "g) applied to the TLG plate~ 1be 
~on of.add!Jc:t~~QJll(in ~ DNA \VIS·~ OJl !lrec:oven' of9~ •. 
as derived frorn the postlabeq_ of a staiidard DNA Sainple äddu:cted wilb 
eH]DMBA (see below). Background radioactivity was determined in spots:c:ut 
from the TI..C sheet 2 cm above· ~ I. The ~ffi~ient Qf\'liiance :QNhe 
background radioacdvity Qf·diffcre~t s(Jeet.s was 20% .<!W=F c;p.m.; 1 ~; 
n "'" i4). Withii'i a sbeet, the'~ility. was 4 c.p.m. as derived_~trom S pa1ts 
oftwo~~ measured t cmapart' Comb~ dle ~ ~Uity 
with the stati5tical ·Counting eiror derived from. the Poisson.distribution·ofthe 
radioactlve.dei:a:y (4 c.p.m~ as. 1 so in our· rneasuternCnu), die umit of detectiem 
of an adauct spot at a signi.ficance level of 95'% was 11 net c.p.m,, 11üs· i$ 
eqUivileni .. ·. · t0 a c:qnce~on of S ~ucü .~r 1o' ONA nuclecJtides. 
DNA isoJatecU~ 8nima1s treated With (3H]DMBA was used as a standard 
for a(ljU$ling ~·3:zP-~ütg~data 10. ad.duct coDC;e~Jtr:atiQns. NJnc pc;tQ:Dt .of 
the
3
. · ~·~ with the 'tfitium:~ w~d~J?l~ "Y 3:ZP.~r'JIIe 
2P-poStiabClirig ·procedure (mean öf four repllcates;, b8sed .on lhe sum of'ail 
adducts); As an approximadon;.~ same norrnalizatiQn fac:tQ~: was used fo~:·:aU 
adducts. 
l~try 
~ ~~r~fr.Ce put·9r:mc~ ~)'~- WJU'P~ ~;.on a ~~ ~,and 
fiXed in 4% fol'niälin, O;S% lleiairiethyl~ '·för afleast 3cweeks. The 
sk:Ut was embeddecl m:Rar&pJast panaffin ~onoj~;Scientific inc., AtllY? netand) 
ind cut irito2-~.plß thin secqClßs~.AsmaU irtfesililal~~QD was.~-tQ ~tro1 
thr the Staining effidency. Tbe seeaiOris Wele Slaintid immünohiStochtmiaruy thr 
~ralion.Qf BnlUintb'DNA(9). Nuclei of (:ells whii::h werein S-phase during 
Bi'dU' staißcd. nxt. . Tt.e=Cäl-~ris weze-·SCailiH:d for'areäs ofhighest BidU;.incorpamtion 
in order to measure rhe. maximum: paSSible ·response of eacb individual animal. 
Here; ~ ~ ()f7® ~ls were counted ~ -~ ~ing iM.ex ~ ~clilated 
utbe;fräaiOßof'ri:id ~OS 81110iiS ~ q;ithelifd cells .• ForcalCUJ.i~ the numbü 
of·cellS perWiit lCngtb,,the·c~istatac:c covercd by the 700 'Cells was alsO. measured. 
Due toJ~Iu:li~]~rQbl~.widielllbc.d®ls and ~ttmgthe valucs.ofone m~ (iatency .tJtriod: 7-,S wedcs). ~ ;Mt. avai18ble. 
R$Ults älid ~ioö 
DNA a4i/.Ucts' .Qiid 141.ertcyc time 
The cumulapve skip-:-pq»illor,na incidence of mice treated twice 
weeldy with DMBA.and·TPA :is shown in Figure 1. Thefirst 
anilnäl. showed a papifioma alter 7.5 weekS of treatment; the 12th 
1110~~r 1:5!6 w~~. Th~e~~Qt was~ a~ w~k 
17. DMBA .adducts in the epidennal DNA of each individual 
mouse were detennined by 32P-postlabeling. One adduct (1 in 
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PerlDei of treatmerit'[WNicl), 
Flg. t. C!wnulative skin,papiUQIIII i®i!ience in a Sr"®P {)_f 14 f~c;NMRI 
mice ~r twice wPfy -~ With. QMBA ~·.;s nlnolJ iiil TPA (3 
iunob~ The tline of. tlle· firit appearance of a papillomä Wäs; re~- for 
each animll. All mic:e were idlJed·. after 17 wecb of~ (arrowl. 
Fig~ 2. 32P-PoS1Jabclin8 TLC map of DMBA -nucieotidc adduds ,ftom 
epiderllial DNA ofa NMlU mousc Which bad beeil tteated with 2.S nmol 
DMBA and 3 nmol TPA twice wcckly for 17 w •. 
Figure 2) was seen in all 14 animals. Adducts 2 and 3 were 
detectable in .all but one. animal. Additional adducts were 
occasionally (in 1-3 mi~) äbove the limitofdeteetion, makin~ 
a tot~l-of eight diffe~nt ~dllcts. As ex~ from tlfelow do8e 
of DMBA administered (2.5 .nmol = 0.64 J'g; twiee weeldy), 
measured.concentrations of single adductstari&ecJJ)Ctween 8 ,and 
90 x i()-9 n.lQllldduct per n~ol ONA ~u~l~.<le~, f~~ 2. $bow~ 
a postlabelin-g m~ ~ ·~ be ob~ at· these,addllctlevels. 
·The· correlation ofthe three main ·adduets .(~os 1 ,....3) rand the 
sum of a1I ;adducts with ·the lä~ncy period. is ·Sfiown in 'Figure ·3~ 
V~cy sli)'pris'ipg)y.,~ bigiler:~\Jctl~v~ls· wt:re seen in ttl~ püce 
~t bad a.'Jonger latency period. This wasi·true not :orily· fQr the 
sum of an.-adducts (Figure 3~ bottom right) but.alSQ for tWo of 
the most abuncbmt irtdlviduai addJictS (Figpre .3, O,tlfer ~ha,rtS). 
Th~ positive co~lal}Qn was .sigrüficant for adduct 1 (P = 0.03; 
Spearman rank- correla~on coefficient test~ and for the- sum of 
all the adducts (P = Ö.Ö~). For adduct.3," tbe s~griifieance Ievel 
was -somewhat. low~r (P = 0:09). Adc41~ .,Z. show~ .no 
correla,PC:)n. The adduct Ievels ·measured in those· two. mice which 
had not (yet) 'developeda papilioma after 11· weeks were also 
relative~y high: a slim of lland 12 x 10-8 m()l ~duct per mol 
nucl®tide was nteasu~. Tbis fmding glves, fluther s~pport to 
the un~xpected correlation of long latency periods with high 
adduct Ievels. 
When the ptesentadillitt. ~s ~ com~ to thO:~'publWied 
(10), ~ ·v.ery ~ntative· ~ign.ment could desitp1ate adduct 1 as a 
deoxyguanosine adduct, while adducts 2 -and 3 :could be 
deOxyadenösine addUets .. Different adduc.tS forme<~ by,· the .same 
catcirtogen can have diff~~l)t biological a,nsequen~. A 
correlation Qf adduct Ievels with a measure .of risk can oilly be 
expected. for dangerous adducts. More than 90% of the sldn 
papillomas initiated by DMBA contain an A~t9-'T transvenion 
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Fig. J. Correlalion of DMBA -nucleoti.de adduc:t Ievels from epidennal 
DNA of NMRI mice with the latency period for lhe appearance of a 
papilloma after twice weekly dermal treatment for 17 weeks with DMBA 
(2.5 mnol) Bild TPA (3 nmol). Correlations are shown for ehe lhree major 
adduct spots and for the swn of up to cight adducts. Speannan rank 
correlation coefficient test: 1, P = 0.03; 3, P = 0.09; E, P = O.OS. 
in codon 61 (A1B2) of the Ha-ras gene (11). Guanine in codon 
12, on the other band, was not found to be substituted. It would 
be premature, however, to consider the major adduct seen in this 
chronic study (adduct 1) an innocuous DNA modification. In 
another report on carcinogen-specific mutation of Ha-ras during 
mouse skin carcinogenesis, a small proportion of DMBA-induced 
tumours were activated at codon 12, presumably by changes at 
one oftwoG residues (12). Furthennore, it cannot be excluded 
that adducts which are not particularly strong in rtlS activation 
result in other types of mutations, for instance strand breaks after 
depurination. This discussion illustrates that the total Ievels of 
adducts can only represent an approximate risk marker but, on 
the other band, one should not regard any adduct as completely 
harmless. 
CeU division and latency time 
The rate of accumulation of mutatiorm from promutagenic DNA 
adducts is dependent on the number of proliferating cells and 
on the. rate of cell division (13, 14). An inverse correlation 
between one of these variables and the papilloma-latency time 
could therefore be expected. The ·analysis of our data is shown 
in Figure 4. Neither labeling index (A) nor cell number (B) 
showed any correlation with the papilloma-lalency time. Although 
the labeling index varied more than threefold within the group 
of mice under analysis, the individual response of the normal 
epidennis to the mitogenic activity of TP A did not correlate with 
the rate of papilloma fonnation. 
Cell division and DNA adducts 
The concentration of DNA adducts is dependent on the rates of 
fonnation and repair, and on the rate of dilution by DNA 
synthesis. With each round of DNA replication, the adduct 
concentration is divided in half because the newly synthesized 
strand does not contain adducts. The higher the rate of cell 
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Ji1g. 4. Correlation of the labeling iDdex for DNA replication (A) 8lld of the 
number of ceUs per mm epidcrmis (B) with the latenc:y period for lhc 
appeanncc of the first papilloma in NMRI micc after ~ weekly dcmJal 
treatmcnt for 17 weeks with 2.5 nmol DMBA and 3 mnol TPA. No 
significant correlation. 
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F1g. S. Corrdation of the DMBA-nucleotide adduct Ievel (no. I) with the 
labeling indcx for DNA replication in the cpidermis of NMRI mice after 
twice weeldy dermal treaanent for 17 weelal witb DMBA (2.~ nmol) Bild 
TPA (3 nmol). Spcannan rank correlation coefticiept text: P = 0.02. 
division, therefore, the 1ower the adduct concentration measured 
in the isolated DNA. This phenomenon could indeed be seen in 
ihis study and is illustraled in Figure S: the concentration of 
adduct 1 was lowest in those individuals that showed the highest 
labeling index (P = 0.02, Speannan rank correlation coeflicient 
test). This could also explain the unexpected correlation between 
low adduct Ievels and shon tumor latency period: individuals with 
high susceptibility to the mitogenic activity of TP A are expected 
to show a lower average Ievel of DNA adducts. 
CeU type specificity 
The question remains why the individual tumor latency was not 
correlated with any of our data on cell division. The problem 
could have its roots in the fact that both the rates of DNA 
replication and the numbers of cells 'at risk' were determined 
without accounting for the cell type, for the Status of the cells 
in the multi-stage process of carcinogenesis, and for the question 
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whether the cells have the ability to replicate. Information on 
the cell division kinetics in premalignant clones of cells might 
be required for such a correlation to become apparent. 
Biomonitoring and molecular epidemiology 
Our da1a could have important consequences for the interpretation 
of results from biomonitaring human exposure to carcinogens 
by measuring DNA adduct Ievels. In such studies, it is very 
tempting to use DNA adduct Ievels not only as an exposure 
marker but also to interpret individual differences in tenns of 
different individual cancer risks. Our data indicate, however, that 
adduct Ievels measured in a target tissue could even be negatively 
correlated with the individual risk for cancer development, 
probably because of differences in the rate of cell division acting 
as a confounding factor. 
Our data are strictly valid only for the skin-papilloma model 
used with repeated administration of both initiating and promoting 
agents and should be extrapolated to other situations with caution. 
On the other band, most human biomonitaring studies are based 
on DNA from peripheral lymphocytes which rarely represent 
target cells. It is concluded that DNA adduct Ievels measured 
in human samples are unlikely tobe of a general predictive value 
for an individual cancer risk. 
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